Literature DB >> 14963856

[A reversible posterior leukoencephalopathy syndrome].

F López-García1, F Amorós-Martínez, A P Sempere.   

Abstract

INTRODUCTION AND
METHOD: The reversible posterior leukoencephalopathy (RPLS) was initially described by Hinchey et al in patients hospitalized due to different acute process that cause hypertension and renal disease that were being treated with immunosuppressive agents. Clinically it produces an acute or subacute encephalopathy that usually agrees with a fast increase of blood pressure. Neuroimaging technique demonstrated abnormalities involving the white matter, especially bilateral edema in the posterior portions of the cerebral hemispheres, although it can also affect to any other cerebral area, trunk or cerebellum. The production mechanism is not well know. In case of hypertensive encephalopathy and eclampsia of pregnancy it is believed to be caused by vascular and endothelial autoregulation alterations, and when it's related to immunosuppressors the edema seems to have a cytotoxical origin. The particularity that defines the RPLS is that, in most cases, neurological symptoms and white matter lesions disappear after anti hypertensive treatment or when immunosuppressive agents is ceased.
CONCLUSION: The RPLS is an uncommon neurological complication, however each time more news cases appear in the medical literature. The excellent evolution and treatment response that these patients show and the full clinical and radiological recuperation suggest the need of its early identification to avoid unnecessary diagnostic studies or wrong treatments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963856

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  3 in total

Review 1.  Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature.

Authors:  Anmol Dhillon; Celso Velazquez; Chokkalingam Siva
Journal:  Rheumatol Int       Date:  2012-07-24       Impact factor: 2.631

2.  Neurological Complications following Blood Transfusions in Sickle Cell Anemia.

Authors:  Hana Alharbi; Nayaab Khawar; Jolanta Kulpa; Anne Bellin; Simona Proteasa; Revathy Sundaram
Journal:  Case Rep Hematol       Date:  2017-01-03

3.  Clinical characteristics and outcomes of patients admitted to hospitals for posterior reversible encephalopathy syndrome: a retrospective cohort study.

Authors:  Abbas Alshami; Asseel Al-Bayati; Steven Douedi; Mohammad A Hossain; Swapnil Patel; Arif Asif
Journal:  BMC Neurol       Date:  2021-03-09       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.